Evidence map›Paper›PMID 34460820›Full record

ArticlePLoS neglected tropical diseases2021

Evidence of chikungunya virus infections among febrile patients at three secondary health facilities in the Ashanti and the Bono Regions of Ghana.

Jonathan Akwasi Adusei, Patrick Williams Narkwa, Michael Owusu, Seth Agyei Domfeh, Mahmood Alhassan, Emmanuel Appau, Alimatu Salam, Mohamed Mutocheluh

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. The Seroprevalence and Hidden Burden of Chikungunya Endemicity and Malaria Mono- and Coinfection in Nigeria.International journal of environmental research and public health · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Jonathan Akwasi AduseiDepartment of Clinical Microbiology, School of Medicine and Dentistry, Kwame Nkrumah University of Science and Technology, KNUST Main Campus, Kumasi, Ghana.ORCID 0000-0002-8328-5691
Patrick Williams NarkwaDepartment of Clinical Microbiology, School of Medicine and Dentistry, Kwame Nkrumah University of Science and Technology, KNUST Main Campus, Kumasi, Ghana.ORCID 0000-0003-2490-7902
Michael OwusuDepartment of Medical Diagnostics, Faculty of Allied Health Sciences, Kwame Nkrumah University of Science and Technology, KNUST Main Campus, Kumasi, Ghana.ORCID 0000-0001-5066-150X
Seth Agyei DomfehDepartment of Clinical Microbiology, School of Medicine and Dentistry, Kwame Nkrumah University of Science and Technology, KNUST Main Campus, Kumasi, Ghana.ORCID 0000-0002-1689-7663
Mahmood AlhassanDepartment of Clinical Microbiology, School of Medicine and Dentistry, Kwame Nkrumah University of Science and Technology, KNUST Main Campus, Kumasi, Ghana.
Emmanuel AppauDepartment of Clinical Microbiology, School of Medicine and Dentistry, Kwame Nkrumah University of Science and Technology, KNUST Main Campus, Kumasi, Ghana.
Alimatu SalamManhyia District Hospital, Manhyia, Kumasi, Ghana.ORCID 0000-0002-8731-0196
Mohamed MutocheluhDepartment of Clinical Microbiology, School of Medicine and Dentistry, Kwame Nkrumah University of Science and Technology, KNUST Main Campus, Kumasi, Ghana.ORCID 0000-0002-1396-5085
Kwame Nkrumah University of Science and Technology · GH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChikungunya is now of public health concern globally due to its re-emergence in endemic areas and introduction into new areas of the world. Worldwide, the vectors for transmission of the chikungunya virus are Aedes mosquitoes and these are prevalent in Ghana. Despite its global significance, the true burden of chikungunya virus infection in Ghana is largely unknown and the threat of outbreak remains high owing to international travel. This study sought to determine chikungunya virus infection among febrile patients suspected of having malaria infections at some selected health facilities in the Ashanti, Bono East, and Bono Regions of Ghana. METHODOLOGY: This cross-sectional study recruited six hundred (600) febrile patients suspected of having malaria who submitted their clinical samples to the laboratories of the selected health facilities for the diagnosis of their infections. Five to ten millilitres (5-10ml) of venous blood were collected from each study participant. Sera were separated and tested for anti-chikungunya (IgM and IgG) antibodies using InBios ELISA kit following the manufacturer's instruction. Samples positive for chikungunya IgM and IgG were selected and tested for chikungunya virus RNA using Reverse Transcription-quantitative Polymerase Chain Reaction. Malaria Rapid Diagnostic Test kits were used to screen the participants for malaria. Structured questionnaires were administered to obtain demographic and clinical information of the study participants.

resultOf the 600 samples tested, the overall seroprevalence of chikungunya was 6%. The seroprevalence of chikungunya IgM and IgG antibodies were 1.8% and 4.2% respectively. None of the chikungunya IgM and IgG positive samples tested positive for chikungunya RNA by RT-qPCR. Of the 600 samples, tested 32.3% (194/600) were positive for malaria parasites. Malaria and chikungunya co-infection was detected in 1.8% (11/600) of the participants.

conclusionFindings from the current study indicate low-level exposure to the chikungunya virus suggesting the virus is circulating and potentially causing morbidity in Ghana.

Indexed as

AdolescentAdultAgedAged, 80 and overAntibodies, ViralChikungunya FeverChikungunya virusChildChild, PreschoolCross-Sectional StudiesEnzyme-Linked Immunosorbent AssayFemaleFeverGhanaHumansInfantAntibodies, Viral

Identifiers

PMID34460820
PMCPMC8432890
OpenAlexW3198366605

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.